UBS Group (UBS) has upsized its cash tender offers for certain of its debt securities to about $5.85 billion from $4 billion, the company said Friday.
The offers expired at 5 pm ET Thursday, with settlement expected Monday.
The company said all maximum purchase notes that have been validly tendered by the expiration date have been accepted for purchase.
UBS Group (UBSG.SW) on Thursday priced concurrent and separate offers to redeem nine series of Credit Suisse Group-issued outstanding senior notes.The offers cover 750 million pounds sterling of 7.375% notes due Sept. 7, 2033; $697.1 million of 6.442% notes due Aug. 11, 2028; and $2.25 billion of 4.282% notes due Jan. 9, 2028. The offers also include up to $4 billion of six other series of outstanding notes maturing in 2029, 2031 and 2033.The Swiss banking group will close the offer on Thursday afternoon, with settlement expected by Sept. 14.
Paradigm Biopharmaceuticals (ASX:PAR) drew down the remaining balance of tranche 4, valued at $2 million, under its $27 million convertible note facility with Obsidian Global Partners, according to a Friday Australian bourse filing.Following the drawdown, about $5 million remains available under the facility, providing continued financial flexibility to support phase 3 execution and broader commercial readiness activities, the filing added.The company's shares plunged 13% in recent Friday trade.
Bank of Chongqing (HKG:1963, SHA:601963) issued 5 billion yuan of three-year fixed-rate green bonds, according to a Friday filing with the Shanghai bourse.The bonds have a coupon rate of 1.59%. Proceeds will go to green projects, the filing said.